{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:26:53Z","timestamp":1744630013073},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10792-019-01244-z","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T16:23:51Z","timestamp":1575303831000},"page":"841-847","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study"],"prefix":"10.1007","volume":"40","author":[{"given":"Irini","family":"Chatziralli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenia","family":"Bourouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Bagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kitsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047\u20131053","journal-title":"Diabetes Care"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227\u20131239","journal-title":"N Engl J Med"},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.01.004","volume":"90","author":"R Madonna","year":"2017","unstructured":"Madonna R, Balistreri CR, Geng YJ, De Caterina R (2017) Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches. Vasc Pharmacol 90:1\u20137","journal-title":"Vasc Pharmacol"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/archopht.1994.01090230090028","volume":"112","author":"F Malecaze","year":"1994","unstructured":"Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J (1994) Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 112:1476\u20131482","journal-title":"Arch Ophthalmol"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1167\/iovs.15-16854","volume":"56","author":"Y Xu","year":"2015","unstructured":"Xu Y, Cheng Q, Yang B, Yu S, Xu F, Lu L, Liang X (2015) Increased sCD200 levels in vitreous of patients with proliferative diabetic retinopathy and its correlation with VEGF and proinflammatory cytokines. Invest Ophthalmol Vis Sci 56:6565\u20136572","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","volume":"112","author":"PT Yeh","year":"2005","unstructured":"Yeh PT, Yang CM, Yang CH, Huang JS (2005) Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology 112:2095\u20132102","journal-title":"Ophthalmology"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0161-6420(83)34540-1","volume":"90","author":"AP Schachat","year":"1983","unstructured":"Schachat AP, Oyakawa RT, Michels RG, Rice TA (1983) Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 90:522\u2013530","journal-title":"Ophthalmology"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/09286580500227068","volume":"12","author":"E Soto-Pedre","year":"2005","unstructured":"Soto-Pedre E, Hernaez-Ortega MC, Vazquez JA (2005) Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmic Epidemiol 12:335\u2013341","journal-title":"Ophthalmic Epidemiol"},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/archopht.1992.01080160084037","volume":"110","author":"GC Brown","year":"1992","unstructured":"Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC Jr. (1992) Reoperation following diabetic vitrectomy. Arch Ophthalmol 110:506\u2013510","journal-title":"Arch Ophthalmol"},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/02713680903572491","volume":"35","author":"H Yan","year":"2010","unstructured":"Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y (2010) Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy. Curr Eye Res 35:308\u2013313","journal-title":"Curr Eye Res"},{"key":"1244_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.ophtha.2003.08.043","volume":"111","author":"VS Hershberger","year":"2004","unstructured":"Hershberger VS, Augsburger JJ, Hutchins RK, Raymond LA, Krug S (2004) Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings. Ophthalmology 111:1215\u20131221","journal-title":"Ophthalmology"},{"key":"1244_CR12","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1167\/iovs.14-15112","volume":"55","author":"DY Kim","year":"2014","unstructured":"Kim DY, Kim JG, Kim YJ, Joe SG, Lee JY (2014) Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy. Invest Ophthalmol Vis Sci 55:7040\u20137046","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1244_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamaophthalmol.2014.287","volume":"132","author":"AR Bhavsar","year":"2014","unstructured":"Bhavsar AR, Torres K, Glassman AR, Jampol LM, Kinyoun JL, Diabetic Retinopathy Clinical Research Network (2014) Evaluation of results 1\u00a0year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy. JAMA Ophthalmol 132:889\u2013890","journal-title":"JAMA Ophthalmol"},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1755-3768.2009.01821.x","volume":"89","author":"PT Yeh","year":"2011","unstructured":"Yeh PT, Yang CH, Yang CM (2011) Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy. Acta Ophthalmol 89:634\u2013640","journal-title":"Acta Ophthalmol"},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2015.15217","volume":"314","author":"JG Gross","year":"2015","unstructured":"Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW (2015) Panretinal photocoagulation vs intravitreous Ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 314:2137\u20132146","journal-title":"JAMA"},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"e101253","DOI":"10.1371\/journal.pone.0101253","volume":"9","author":"B Wu","year":"2014","unstructured":"Wu B, Wu H, Liu X, Lin H, Li J (2014) Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials. PLoS ONE 9:e101253","journal-title":"PLoS ONE"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"e42701","DOI":"10.1371\/journal.pone.0042701","volume":"7","author":"C Schmucker","year":"2012","unstructured":"Schmucker C, Ehlken C, Agostini HT, Antes G, Ruecker G, Lelgemann M, Loke YK (2012) A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus gold standard. PLoS ONE 7:e42701","journal-title":"PLoS ONE"},{"key":"1244_CR18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","volume":"13","author":"JT Holladay","year":"1997","unstructured":"Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388\u2013391","journal-title":"J Refract Surg"},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1097\/IAE.0000000000000723","volume":"35","author":"MP Simunovic","year":"2015","unstructured":"Simunovic MP, Maberley DA (2015) Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: a systematic review and meta-analysis. Retina 35:1931\u20131942","journal-title":"Retina"},{"key":"1244_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-0420.2007.01021.x","volume":"86","author":"JM Ruiz-Moreno","year":"2008","unstructured":"Ruiz-Moreno JM, Montero JA, Lugo F, Amat P, Staicu C (2008) Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmol 86:231\u2013232","journal-title":"Acta Ophthalmol"},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/IAE.0000000000000058","volume":"34","author":"K Ferenchak","year":"2014","unstructured":"Ferenchak K, Duval R, Cohen JA, MacCumber MW (2014) Intravitreal bevacizumab or postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy. Retina 34:1177\u20131181","journal-title":"Retina"},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpb.2016.09.003","volume":"108","author":"MR Moreno","year":"2016","unstructured":"Moreno MR, Tabitha TS, Nirmal J, Radhakrishnan K, Yee CH, Lim S, Venkatraman S, Agrawal R (2016) Study of stability and biophysical characterization of ranibizumab and aflibercept. Eur J Pharm Biopharm 108:156\u2013167","journal-title":"Eur J Pharm Biopharm"},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"e0159553","DOI":"10.1371\/journal.pone.0159553","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wang W, Gao Y, Lan J, Xie L (2016) The efficacy and safety of current treatments in diabetic macular edema: a systematic review and network meta-analysis. PLoS ONE 11:e0159553","journal-title":"PLoS ONE"},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2015.4070","volume":"134","author":"RL Avery","year":"2016","unstructured":"Avery RL, Gordon GM (2016) systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis. JAMA Ophthalmol 134:21\u201329","journal-title":"JAMA Ophthalmol"},{"key":"1244_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/IAE.0000000000001673","volume":"38","author":"E Chelala","year":"2018","unstructured":"Chelala E, Nehme J, El Rami H, Aoun R, Dirani A, Fadlallah A, Jalkh A (2018) Efficacy of intravitreal ranibizumab injections in the treatment of vitreous hemorrhage related to proliferative diabetic retinopathy. Retina 38:1127\u20131133","journal-title":"Retina"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jamaophthalmol.2013.2015","volume":"131","author":"Diabetic Retinopathy Clinical Research Network","year":"2013","unstructured":"Diabetic Retinopathy Clinical Research Network (2013) Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. JAMA Ophthalmol 131:283\u2013293","journal-title":"JAMA Ophthalmol"},{"key":"1244_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2008","unstructured":"Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, Eid Farah M, Pieramici DJ, Berrocal MH, Sanchez JG (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213\u2013216","journal-title":"Br J Ophthalmol"},{"key":"1244_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2008.0092","volume":"25","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Koh HJ (2009) Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy. J Ocul Pharmacol Ther 25:173\u2013174","journal-title":"J Ocul Pharmacol Ther"},{"key":"1244_CR29","first-page":"502","volume":"31","author":"L Ficker","year":"1990","unstructured":"Ficker L, Meredith TA, Gardner S, Wilson LA (1990) Cefazolin levels after intravitreal injection. Effects of inflammation and surgery. Invest Ophthalmol Vis Sci 31:502\u2013505","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1244_CR30","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1167\/iovs.12-10164","volume":"53","author":"M Kakinoki","year":"2012","unstructured":"Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M (2012) Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Invest Ophthalmol Vis Sci 53:5877\u20135880","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01244-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:05:01Z","timestamp":1665140701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01244-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01244-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, or other equity interest), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the 1964 Declaration of Helsinki and its later amendments. The study was approved by the institutional review board of the participating hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}